2023年《中国高血压防治指南》更新临床实践  

Clinical practice of 2023 hypertension guidelines update

作　　者：孙恕 易松 SUN Shu;YI Song(Department of Cardiology,Yichun People's Hospital,Yichun 336028,China)

机构地区：[1]宜春市人民医院心内科,336028

出　　处：《心电与循环》2023年第3期203-206,212,共5页Journal of Electrocardiology and Circulation

摘　　要：高血压不仅仅是目前中国患病人数最多的慢性非传染性疾病,同时也是导致城乡居民心血管疾病死亡、致残的最重要危险因素。2018年我国成人高血压患病率处于下降趋势,但高血压患者的知晓率、治疗率和控制率已取得较好成绩,但总体仍处于较低的水平。因此,对于高血压的诊断、启动降压治疗时机、继发性高血压诊治、特殊人群高血压诊治都需要规范。我国2022年更新《中国高血压临床实践指南》,2023年更新《中国高血压防治指南》,对于临床实践有指导作用,但仍有一些问题需进一步探讨。Hypertension is not only currently the most prevalent chronic non-communicable disease in China,but also a leading risk factor of cardiovascular death and disability among residents.Although the prevalence of adult hypertension in China is on a downward trend in 2018,diagnosis,awareness,and control of hypertension remained at a relatively low level.So,it is very important in diagnosis of the hypertension,diagnosis and treatment on secondary hypertension,timing of antihypertensive treatment,diagnosis and treatment of hypertension in special population.China updated the"China hypertension clinical practice guidelines"in 2022 and the"China hypertension prevention and treatment guidelines"in 2023,which have a guiding effect on clinical practice,but there are still some problems that need to be further explored.

关 键 词：高血压 诊断 治疗 

分 类 号：R54-5[医药卫生—心血管疾病] G23[医药卫生—内科学]